Research News

Top 20 pharma companies based on R&D investment 2015-16

Tuesday, 28 February 2017 10:01

IgeaHub published an infographic showing the top 20 pharma companies based on their R&D investment in 2015-16. The infographic was based on data extracted from the 2016 EU Industrial R&D Investment Scoreboard. The Scoreboard comprises the 2500 companies investing the largest sums in R&D in the world (€21m or more in each case) and an additional number of companies to cover the top 1000 R&D investing companies based in the EU (R&D of €6m or more). In total, there are 2909 parent companies incorporated in the 2016 Scoreboard. The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (JRC-IPTS/DG RTD) as part of its Industrial Research and Innovation Monitoring and Analysis activity (IRIMA). In this 11.6 Mb report, the term EU company refers to companies whose ultimate parent has its registered office in a Member State of the EU. Likewise, non-EU company applies when the ultimate parent company is located outside the EU.

Shaping the future of research

Monday, 27 February 2017 10:57

NIHR Medical Director Nick Lemoine forwarded a letter from Chief Scientific Advisor Chris Whitty and Director of Science, Evidence and Research, Louise Wood. He said they "wish to see more clinical and public health research conducted in the areas of the country and communities with the highest need. They also highlight the importance of research in primary care, public health and social care and urge more to be done in these domains. There are also observations about the interface with the life sciences industry in this country, and the need to ensure that researcher training is fit for future purpose." Please read their letter for full details.

Expression of interest in joining an NIHR panel

Friday, 24 February 2017 10:35

If you might be interested in joing an NIHR panel, please complete the form. More information about the work of the panels can be found on the NIHR website.

METRIC Study closed for recruitment - add-on study funded

Friday, 24 February 2017 10:15

The NIHR HTA funded Metric study (MR Enterography or ulTRasound In Crohn’s disease; “Diagnostic accuracy for the extent and activity of newly diagnosed and relapsed Crohn’s disease: a multicentre prospective comparison of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over”) has closed to recruitment; data collection and analysis are underway. The research team led by Prof Stuart Taylor and Dr Andrew Plumb were successful in securing £358,183 funding from the HTA for an add on study (MRI enterography as a predictor of disabling disease in newly diagnosed Crohn's disease) to develop a prognostic model for future disabling disease in those newly diagnosed with Crohn's disease. In particular, the group will investigate whether findings on MR enterography at diagnosis are predictive of a worse long-term outcome, over and above existing prognostic markers. Co-investigators: Ailsa Hart, Andrew Plumb, Gauraang Bhatnagar, Nicola Muirhead, John Hamlin, Stuart Bloom, Susan Mallett, Ilan Jacobs, Susan Tebbs, Simon Travis, Stephen Morris, Steve Halligan.

Page 9 of 38